中醫(yī)藥是中國優(yōu)秀傳統(tǒng)文化的代表，經(jīng)典名方作為中藥復方的典型代表，在藥品注冊方面有了新的突破，但是，也應注意到由此帶來的研究挑戰(zhàn)，尤其是非臨床安全性研究方面的挑戰(zhàn)，另外在臨床定位、藥理基礎(chǔ)研究方面，研發(fā)者和生產(chǎn)單位還有很長的路要走，應提前為經(jīng)典名方的長遠發(fā)展做足準備。

Traditional Chinese medicine is the representative of Chinese excellent traditional culture, and it's congratulated that the classical herbal formulae get a new breakthrough in drug registration as the typical representative of traditional Chinese medicine formula. Meanwhile, we should also pay attention to the challenge of research in the new situation, especially for nonclinical safety research. Otherwise, there are so many job to do for research institutions and pharmaceutical companies on the studies of clinical orientation and pharmacology materia basis. It is important to prepare early beause it is a long-term of the development of the classic herbal formulae.